All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2016-003452-75 | A PHASE 2B RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL ADAPTIVE 2-STAGE, MULTI-CENTRE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL PTG-100 INDUCTION IN SUBJECTS WITH MODERATE TO SEVERE... | 2018-03-26 | due-trials |
Reported results | 2018-001984-21 | Phase 2 Study of PTG-300 in Non-Transfusion Dependent (NTD) and Transfusion-Dependent (TD) ß-Thalassemia Subjects with Chronic Anemia Studio di fase 2 di PTG-300 in soggetti affetti da beta-talasse... | 2020-03-31 | due-trials |
Reported results | 2018-004423-36 | An Open Label Extension Study of PTG-300 in Non-Transfusion Dependent (NTD) and Transfusion-Dependent (TD) ß-thalassemia Subjects Studio di estensione in aperto su PTG-300 in soggetti affetti da be... | 2020-04-06 | due-trials |
Not reported | 2019-004469-41 | A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects with Moderate to Severe Active Ulcerative Coli... | 2023-07-03 | due-trials |
Other | 2021-004732-29 | A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera Studio di fase 3 per valutare il mimetico dell’epcidina rusfertide (PTG-300) in pazienti affetti da ... | not-yet-due |